(Q42063048)

15 October 2017

title

Management of hypertensive emergencies (English)

1 reference

15 October 2017

N M Kaplan

1

1 reference

15 October 2017

language of work or name

English

0 references

publication date

1 November 1994

1 reference

15 October 2017

1 reference

15 October 2017

volume

344

1 reference

15 October 2017

issue

8933

1 reference

15 October 2017

page(s)

1335-1338

1 reference

Blood pressure, stroke, and coronary heart disease

15 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990696-3

7 January 2021

The Effects of Blood Pressure Reduction in Older Patients: An Overview of Five Randomized Controlled Trials in Elderly Hypertensives

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990696-3

7 January 2021

Pathophysiology and management of hypertension in acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990696-3

7 January 2021

A comparison of the acute hypotensive effects of two different doses of nifedipine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990696-3

7 January 2021

Oral labetalol versus oral nifedipine in hypertensive urgencies in the ED.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990696-3

7 January 2021

Autoregulation of brain circulation in severe arterial hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990696-3

7 January 2021

Cerebral blood flow and its pathophysiology in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990696-3

7 January 2021

Prevalence of Renovascular Hypertension in Patients with Grade III or IV Hypertensive Retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990696-3

7 January 2021

Detection of renovascular hypertension. State of the art: 1992

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990696-3

7 January 2021

Falsely elevated urinary excretion of catecholamines and metanephrines in patients receiving labetalol therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990696-3

7 January 2021

Prognosis in untreated hypertensive vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990696-3

7 January 2021

Drug therapy in hypertension with hemorrhagic hypertensive retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990696-3

7 January 2021

The effectiveness of long-term treatment of malignant hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990696-3

7 January 2021

The effect of treatment on mortality rates in severe hypertension; a comparison of medical and surgical regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990696-3

7 January 2021

Results of treatment in malignant hypertension: a seven-year experience in 94 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990696-3

7 January 2021

Cerebrovascular aspects of antihypertensive treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990696-3

7 January 2021

Multicenter trial of automated nitroprusside infusion for postoperative hypertension. Titrator Multicenter Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990696-3

7 January 2021

Differential hemodynamic and sympathoadrenal effects of sodium nitroprusside and hydralazine in hypertensive subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990696-3

7 January 2021

Intracranial pressure changes induced by sodium nitroprusside in patients with intracranial mass lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990696-3

7 January 2021

Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990696-3

7 January 2021

Hemodynamic effects of intravenous labetalol in essential hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990696-3

7 January 2021

Cerebral blood flow in patients with severe hypertension, and acute and chronic effects of felodipine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990696-3

7 January 2021

Fenoldopam mesylate versus sodium nitroprusside in the acute management of severe systemic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990696-3

7 January 2021

Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990696-3

7 January 2021

Regulation of sodium balance in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990696-3

7 January 2021

Severe hypertension with cerebral symptoms treated with furosemide, fractionated diazoxide or dihydralazine. Danish Multicenter Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990696-3

7 January 2021

Treatment of hypertensive crisis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990696-3

7 January 2021

10.1016/S0140-6736(94)90696-3

Identifiers

DOI

1 reference

15 October 2017

1 reference